Skip to content

    Colorectal Cancer Health Center

    Font Size

    Colorectal Cancer Prevention (PDQ®): Prevention - Health Professional Information [NCI] - Overview



    Based on solid evidence, harms of ASA use include excessive bleeding, including gastrointestinal bleeds and hemorrhagic stroke.

    Magnitude of Effect: The estimated average excess risk of upper gastrointestinal complications is 10 to 30 per 1,000 people for a period of 10 years, on the higher end for men and on the lower end for women. Risk increases with age.

    Study Design: Evidence obtained from large databases.[15,20]
    Internal Validity: Good.
    Consistency: Good.
    External Validity: Good, data from national databases.

    Hormone therapy (estrogen plus progestin)

    Based on solid evidence, combined hormone therapy (conjugated equine estrogen and progestin) decreases the incidence of invasive CRC.[21]

    Based on fair evidence, combination conjugated equine estrogen and progestin has little or no benefit in reducing mortality from CRC. Data from the Women's Health Initiative (WHI), a randomized, placebo-controlled trial evaluating estrogen plus progestin, with a mean intervention of 5.6 years and a follow-up of 11.6 years showed that women taking combined hormone therapy had a statistically significant higher stage of cancer (regional and distant) at diagnosis but not a statistically significant number of deaths from CRC compared with women taking the placebo.[21]

    Magnitude of Effect: There were fewer CRCs in the combined hormone therapy group than in the placebo group (0.12% vs. 0.16%; HR = 0.72; 95% CI, 0.56-0.94). A meta-analysis of cohort studies observed a RR of 0.86 (95% CI, 0.76-0.97) for incidence of CRC associated with combined hormone therapy.

    There were 37 CRC deaths in the combined hormone therapy arm compared with 27 deaths in the placebo arm (0.04% vs. 0.03%; HR 1.29; 95% CI, 0.78-2.11).

    • Study Design: Randomized controlled trial and cohort studies
    • Internal Validity: Good.
    • Consistency: Good for effect on incidence; N/A for effect on mortality; results were based on one trial.
    • External Validity: Good.

    Estrogen-only therapy


    Based on fair evidence, conjugated equine estrogens do not affect the incidence of, or survival from, invasive CRC.[22]

    Magnitude of Effect: N/A.

    Study Design: One randomized controlled trial.
    Internal Validity: Good.
    Consistency: N/A.
    External Validity: Good.
    1 | 2 | 3 | 4 | 5
    Next Article:

    Today on WebMD

    Colorectal cancer cells
    The right diagnosis is the most important factor.
    man with a doctor
    Our health check will steer you in the right direction.
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    bladder cancer x-ray
    Do you know the warning signs?
    Colon vs Rectal Cancer
    New Colorectal Treatments
    can lack of sleep affect your immune system
    Cancer Facts Quiz
    Virtual Colonoscopy
    Picture of the Colon
    Vitamin D